Prothrombin G20210A and Factor V Leiden mutations in ischemic arterial stroke
INTRODUCTION: Ischemic stroke remains an important public health problem in all over world. It is wellknown that, some type of genetic mutations such as factor V Leiden and prothrombin G20210A contribute to the risk of ischemic venous stroke.
Hafize Nalan Güneş
doaj +1 more source
American College of Medical Genetics Consensus Statement on Factor V Leiden Mutation Testing
American College of Medical Genetics Consensus Statement on Factor V Leiden Mutation ...
W. Grody +4 more
semanticscholar +1 more source
RELATION BETWEEN MATERNAL THROMBOPHILIA AND STILLBIRTH ACCORDING TO CAUSES/ASSOCIATED CONDITIONS OF DEATH [PDF]
OBJECTIVE: To investigate maternal thrombophilia in cases of Stillbirth (SB), also an uncertain topic because most case series were not characterised for cause/associated conditions of death.
Alberico, S +11 more
core +1 more source
Combined Branch Retinal Vein and Artery Occlusion in Toxoplasmosis with Hyperhomocysteinemia, and Mutation of Factor V Leiden [PDF]
Moreover, heterozygosity of a mutation of factor V Leiden; FVL (coagulation factor V gene) was also observed in the case. The patient was diagnosed with branch retinal vein and artery occlusion with hyperhomocysteinemia and mutation of factor V Leiden ...
Dehghani, Mohammad Sadegh +4 more
core +2 more sources
Factor V Leiden Mutation in Cerebrovascular Disease
Several studies indicate a high prevalence of factor V Leiden mutation as the most frequent coagulation defect found in patients with venous thrombosis. The relationship between this mutation and cerebrovascular disease has not been established in adults.
Nur, Buyru +3 more
openaire +2 more sources
Factor V Null Mutation Affecting the Roche LightCycler Factor V Leiden Assay [PDF]
Although the role of factor V as a coagulation factor is more familiar, it has an equally important alternative role as a cofactor for protein C. Activated protein C (APC) is important in a naturally occurring anticoagulant pathway in which it cleaves factor V, thereby controlling the concentrations of factor V.
Mani S, Mahadevan, Paul V, Benson
openaire +2 more sources
Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis [PDF]
Hormone replacement therapy (HRT) increases the risk of venous thrombosis. We investigated whether this risk is affected by carriership of hereditary prothrombotic abnormalities.
A. Rumley +26 more
core +1 more source
Factor V Leiden Mutation in Iraqi Patients with Deep Venous Thrombosis.
Background: Factor V Leiden is considered the most common inherited risk factor for venous thrombosis in Caucasian populations, including those in the Eastern Mediterranean region.
Nasir Al-Allawi +2 more
doaj +1 more source
Factor V Leiden Mutation and its Impact on Pregnancy Complications
Objective: The aim of this prospective study was to find the association between the factor V Leiden mutation and adverse pregnancy outcomes. Methods: This study is an analysis of a prospective observational study of the frequency of placenta-mediated ...
Ľubica Hammerová +3 more
doaj +1 more source
Testing for inherited thrombophilia does not reduce the recurrence of venous thrombosis\ud [PDF]
Background: Inherited thrombophilia is only weakly associated with recurrence in patients with a first venous thrombosis (VT). In spite of this, thrombophilia testing is often performed in these patients. Positive results may influence patient management
Coppens, M. +4 more
core +2 more sources

